General Practitioners

• Smoking Cessation
  If you meet all the qualifications to participate in the ORCA-3 study, you will receive study drug (cytisinicline, placebo, or both) during the 12-week treatment period at no cost to you.  In addition, 1:1 smoking cessation counseling support, no cost study-related medical care, and compensation for your time and participation will be provided.
• Electrocardiogram
  At your next in-clinic visit, the team will perform initial assessments with you. Most studies will require our qualified staff to perform an Electrocardiogram (ECG) and blood work at this visit. All your assessments will be sent to the trial sponsor for approval.

Neurologists

• Neurology
  Princeton Medical Institute (PMI) is the headquarters of Global Medical Institutes, LLC, an investigative research organization that has been conducting clinical trials in the areas of psychiatry, neurology, and general medicine since 1989.
• Epilepsy

Psychiatrists

• Attention Deficit Hyperactivity Disorder (ADHD)
  Attention Deficit-Hyperactivity Disorder is a medical condition that affects how well someone can concentrate due to hyperactivity or inattention. People with ADHD have differences in the parts of their brain that control attention. Symptoms of ADHD could start at a very young age and could continue into adulthood.
• Mental Health
  Post-traumatic stress disorder (PTSD) is a mental health condition that may occur after experiencing or witnessing a traumatic event. It can lead to a wide Read More »
• Psychiatry

Endocrinologist

• Endocrinology
  Dr. Apter is a founding member of the New Jersey Alzheimer Association Scientific Advisory Board and is nationally known as a thought leader in Alzheimer’s Research. He is also a founding member of the American Association of Geriatric Psycho-endocrinology and the International Society of CNS Clinical Trials And Methodology (ISCTM).